Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A new angiotensin ii receptor blocker (ARB) and the thiazide diuretic, chlorthalidone, has been approved as a fixed combination for the treatment of hypertension.

Azilsartan Medoxomil and Chlorthalidone (Edarbyclor®)